BioSpace News Archive

The demand within the global tinnitus market is set to rise at a sound pace in the times to follow.

The global protein analyzers market is popularized by a few dominating products manufactured by as dominant companies operating in the industry.

The global prescription dermatology therapeutics market is growing at a rapid pace due to high prevalence and increase in incidence rate of chronic and infectious dermatological disorders, and new product development and commercialization across the globe.

Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement.

Behavior therapy, also known as behavior analytical and psychotherapy, is a term that broadly refers to the treatment that helps alter self-destructing behaviors in a patient.

Priority Medicines (PRIME) designation supports the potential for lacutamab to benefit Sézary Syndrome patients in need of new treatment options

Observations of rapid recovery noted on chest x-ray and no drug-related Serious Adverse Events reported

Promising long-term safety and effectiveness results from PAD population with extremely complex SFA disease

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced the pricing of an upsized underwritten public offering of 5,040,000 shares of its common stock at a price of $23.00 per share.

Bio-Path Holdings, Inc., a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, announced its financial results for the third quarter ended September 30, 2020 and provided an update on recent corporate developments.